Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/8000
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCLAES, Neree-
dc.contributor.authorJACOBS, Nele-
dc.date.accessioned2008-03-14T22:19:45Z-
dc.date.available2008-03-14T22:19:45Z-
dc.date.issued2007-
dc.identifier.citationBMC Cardiovascular Disorders, 7. p. 1-13-
dc.identifier.issn1471-2261-
dc.identifier.urihttp://hdl.handle.net/1942/8000-
dc.description.abstractBACKGROUND: Cardiovascular diseases (CVD) are the leading cause of death and the third cause of disability in Europe. Prevention programmes should include interventions aimed at a reduction of medical risk factors (hypertension, hypercholesterol, hyperglycemia, overweight and obesity) as well as behavioural risk factors (sedentary lifestyle, high fat intake and low fruit and vegetable intake, smoking). The aim of this study is to investigate the effects of a multifaceted, multidisciplinary electronic prevention programme on cardiovascular risk factors. METHODS/DESIGN: In a randomized controlled trial, one group will receive a maximal intervention (= intervention group). The intervention group will be compared to the control group receiving a minimal intervention. An inclusion of 350 patients in total, with a follow-up of 3 years is foreseen. The inclusion criteria are age between 25-65 and insured by the Onderlinge Ziekenkas, insuring for guaranteed income in case of illness for self-employed. The maximal intervention group receives several prevention consultations by their general practitioner (GP) using a new type of cardiovascular risk calculator with personalized feedback on behavioural risk factors. These patients receive a follow-up with intensive support of health behaviour change via different methods, i.e. a tailored website and personal advice of a multidisciplinary team (psychologist, physiotherapist and dietician). The aim of this strategy is to reduce cardiovascular risk factors according to the guidelines. The primary outcome measures will be cardiovascular risk factors. The secondary outcome measures are cardiovascular events, quality of life, costs and incremental cost effectiveness ratios. The control group receives prevention consultations using a new type of cardiovascular risk calculator and general feedback. DISCUSSION: This trial incorporates interventions by GPs and other health professionals aiming at a reduction of medical and behavioural cardiovascular risk factors. An assessment of clinical, psychological and economical outcome measures will be performed.-
dc.description.sponsorshipDe Onderlinge Ziekenkas-
dc.language.isoen-
dc.publisherBiomed Central-
dc.subject.otherGezondheid en welzijn-
dc.subject.otherCardiovascular Prevention-
dc.titleThe PreCardio-study protocol: a randomised clinical trial of a multidisciplinary electronic cardiovascular prevention programme-
dc.typeJournal Contribution-
dc.identifier.epage13-
dc.identifier.spage1-
dc.identifier.volume7-
local.bibliographicCitation.jcatA1-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.bibliographicCitation.oldjcatA1-
local.identifier.vabbc:vabb:86045-
dc.identifier.doi10.1186/1471-2261-7-27-
dc.identifier.urlhttp://www.biomedcentral.com/content/pdf/1471-2261-7-27.pdf-
item.validationvabb 2010-
item.accessRightsOpen Access-
item.fullcitationCLAES, Neree & JACOBS, Nele (2007) The PreCardio-study protocol: a randomised clinical trial of a multidisciplinary electronic cardiovascular prevention programme. In: BMC Cardiovascular Disorders, 7. p. 1-13.-
item.fulltextWith Fulltext-
item.contributorCLAES, Neree-
item.contributorJACOBS, Nele-
crisitem.journal.issn1471-2261-
crisitem.journal.eissn1471-2261-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
claes.pdfPublished version616.82 kBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

19
checked on Sep 3, 2020

Page view(s)

22
checked on Sep 7, 2022

Download(s)

10
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.